Research reportLeptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia
Introduction
Leptin is a fat cell-derived hormone that signals nutrition status to the hypothalamus weight and sexual behavior (Prolo et al., 1998), and has been discovered as the product of the obese (ob) gene (Zhang and Friedman, 1994). Plasma levels of leptin are found to have strong correlation with body mass index (BMI) and body fat percentage. It has been reported that leptin affects the intracellular lipid concentration via a decrease in the synthesis of fatty acid and cholesterol and an increase in lipid oxidation (Atmaca et al., 2002b, Auwerx and Steals, 1998). Leptin administration has been shown to reduce food intake and weight, suggesting its role in weight regulation (Halaas et al., 1995, Pelleymounter et al., 1995). Recently, many studies focused on leptin levels in psychiatric disorders (bipolar disorder, depression, suicidal attempters, borderline personality disorder) and psychotropic drug use (especially antipsychotics and valproate), but showed inconsistent findings (Kraus et al., 2001, Atmaca et al., 2002a, Atmaca et al., 2002b, Atmaca et al., 2003a, Atmaca et al., 2003b, Atmaca et al., 2003c). Besides, a positive correlation has been shown between serum leptin concentration and total cholesterol, triglyceride, and percentage body fat (Kaplan, 1998). Further, an interaction between leptinergic and serotonergic systems in the central nervous system has been demonstrated (Leibowitz and Alexander, 1998).
Low cholesterol values have been associated with the expression of aggressive and impulsive behavior in a variety of psychiatric disorders, e.g. intermittent explosive disorder (Virkkuncn and Penttinen, 1984) and antisocial personality disorder (Freedman et al., 1995). In depressed patients, low (Glueck et al., 1994, Maes et al., 1997) and high (Apter et al., 1999) cholesterol levels compared with healthy controls have been found. Recently studies have reported that schizophrenic patients using physical violence had lower serum cholesterol levels than those not using physical violence although the difference was not statistically significant (Huang and Wu, 2000). There were few studies systematically evaluating the relationship between different symptomatology, leptin, cholesterol, and BMI. In the present study, the BMI, plasma cholesterol and leptin levels, BDI (Beck Depression Inventory), and BPRS (Brief Psychiatric Rating Scale) were compared in 69 patients with major depressive disorder, 78 schizophrenic patients, and 51 healthy controls. The purpose of this study is to test the hypothesis that the leptin, BMI, and cholesterol should show different relationship among three groups because of different psychiatric status.
Section snippets
Subjects
This study was performed in a subset of peoples from a large study on the evaluation of effects of psychotropic drugs on the lipid metabolism, insulin resistance, and leptin resistance. There were three groups of patients being selected from this sample. We chose sixty nine patients who suffered from major depressive disorder according to DSM-IV (American Psychiatric Association, 1994), seventy eight patients who got a schizophrenic disorder without psychotic depressive disorder. Exclusion
Results
Age, BDI, BPRS, cholesterol and leptin levels, and BMI in all three groups are presented in Table 1. There were no significant differences among the groups for mean age and female / male ratio (p > 0.05). Both cholesterol and leptin levels showed significant differences among the groups. As shown in Fig. 1, plasma leptin and cholesterol levels were significantly lower in patients with major depressive disorder than those schizophrenic patients and healthy controls. In contrast, leptin and
Discussion
The major significant findings of our study were as follows: (1) both low leptin and cholesterol levels in patients with major depressive disorder; (2) both high leptin and cholesterol levels in schizophrenic patients; (3) negative correlations between BDI scores and serum cholesterol or leptin levels in patients with major depressive disorder; (4) positive correlations between serum cholesterol or leptin levels and the length of illness in the patients with schizophrenia; (5) a positive
Acknowledgements
This work was supported by grants CTH-93-1-2B07 from the Catholic Cardinal Tien Hospital. We would also like to thank Ms. C.F. Yang and Mrs. S.C. Hu for their help.
References (38)
- et al.
Serum cholesterol, suicidal tendencies, impulsivity, aggression, and depression in adolescent psychiatric inpatients
Biol. Psychiatry
(1999) - et al.
Leptin
Lancet
(1998) - et al.
Leptin in human plasma is derived in part from the brain, and cleared by the kidneys
Lancet
(1998) - et al.
Hypercholesterolemia and affective disorders
Am. J. Med. Sci.
(1994) - et al.
Leptin in the CNS: much more than a satiety signal
Neuropharmacology
(2003) - et al.
Serum cholesterol levels in paranoid and non-paranoid schizophrenia associated with physical violence or suicide attempts in Taiwanese
Psychiatry Res.
(2000) Leptin, obesity, and liver disease
Gastroenterology
(1998)- et al.
Leptin
Int. J. Biochem. Cell Biol.
(1998) Albumin decrement in depression and cholesterol decrement in mania
J. Affect. Disord.
(1990)- et al.
Low CSF leptin in female suicide attempters with major depression
J. Affect. Disord.
(2004)
Regulation of neuronal and glial proteins by leptin: implications for brain development
Endocrinology
Diagnostic and Statistical Manual of Mental Disorders
Serum leptin and cholesterol values in the suicide attempters
Neuropsychobiology
Serum leptin and cholesterol levels in patients with bipolar disorder
Neuropsychobiology
Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts
Acta Psychiatr. Scand.
Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics
J. Clin. Psychiatry
Serum cholesterol and leptin levels in patients with borderline personality disorder
Neuropsychobiology
Manual for the Beck Depression Inventory
Aggression, suicide, and serotonin: relationships to CSF amine metabolites
Am. J. Psychiatry
Cited by (174)
Adipocytokines levels as potential biomarkers for discriminating patients with a diagnosis of depressive disorder from healthy controls
2024, Journal of Psychiatric ResearchEnvironmental stress during adolescence promotes depression-like behavior and endocrine abnormalities in rats
2024, Behavioural Brain ResearchImpaired eating behaviors but intact metabolic hormone levels in individuals with major depressive disorder and generalized anxiety disorder
2023, Journal of Psychiatric ResearchBody mass index modifies the relationship between dietary iron intake and depressive symptoms among adults: A national population-based cohort
2023, Journal of Affective DisordersThe relationship between depressive symptoms and BMI: 2005–2018 NHANES data
2022, Journal of Affective DisordersA systematic review and meta-analysis of lipid metabolomic signatures of Major Depressive Disorder
2021, Journal of Psychiatric Research